[go: up one dir, main page]

NZ703876A - Methods of using sialic acid and siaic acid precursors for the treatment of kidney disease and related conditions - Google Patents

Methods of using sialic acid and siaic acid precursors for the treatment of kidney disease and related conditions

Info

Publication number
NZ703876A
NZ703876A NZ703876A NZ70387611A NZ703876A NZ 703876 A NZ703876 A NZ 703876A NZ 703876 A NZ703876 A NZ 703876A NZ 70387611 A NZ70387611 A NZ 70387611A NZ 703876 A NZ703876 A NZ 703876A
Authority
NZ
New Zealand
Prior art keywords
sialic acid
treatment
acid
siaic
methods
Prior art date
Application number
NZ703876A
Inventor
Sumant Chugh
Original Assignee
Sumant Chugh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/152,169 external-priority patent/US20110301103A1/en
Application filed by Sumant Chugh filed Critical Sumant Chugh
Publication of NZ703876A publication Critical patent/NZ703876A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Disclosed herein is the use of a sialic acid, a sialic acid precursor or a combination of the foregoing in the treatment or prevention of a diabetic condition or nephrotic syndrome in a subject. Specific embodiments include wherein the sialic acid precursor is N-acetyl-D-mannosamine (ManNAc), Bu4ManNAc, 3,4,6-O-Bu3ManNAc, 1,3,4-O-Bu3ManNAc, N-levulinoyl sialic acid, or N-levulinoylmannosamine, wherein the diabetic condition is diabetic nephropathy, diabetes mellitus, lupus nephritis or primary glomular disease, or characterized by the presence of hyposialylated form of Angpl4, and wherein the nephrotic syndrome is characterised as minimal change disease, focal segmental glomerulosclerosis, membranous nephropathy/membranous glomerulonephritis, membranoproliferative glomerulonephritis or diabetic nephropathy.
NZ703876A 2010-06-05 2011-06-03 Methods of using sialic acid and siaic acid precursors for the treatment of kidney disease and related conditions NZ703876A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35186510P 2010-06-05 2010-06-05
US13/152,169 US20110301103A1 (en) 2010-06-05 2011-06-02 Methods of Treatment
NZ60534411 2011-06-03

Publications (1)

Publication Number Publication Date
NZ703876A true NZ703876A (en) 2016-04-29

Family

ID=55812086

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ703876A NZ703876A (en) 2010-06-05 2011-06-03 Methods of using sialic acid and siaic acid precursors for the treatment of kidney disease and related conditions

Country Status (1)

Country Link
NZ (1) NZ703876A (en)

Similar Documents

Publication Publication Date Title
MY163539A (en) Antibody fc variants
MY176863A (en) Ibat inhibitors for treatment of metabolic disorders and related conditions
WO2009050567A3 (en) Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
IL238283A0 (en) Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level
EA201391028A1 (en) HYPOLIPIDEMIC ANTI-DIABETIC MEANS
AP2011005978A0 (en) 2, 4 diaminopyrimidines for the treatment of diseases characterised by excessive or abnormal cell proliferation.
TN2011000368A1 (en) Fused ring compound and use thereof
HK1211232A1 (en) Exendin-4 derivatives as dual glp1/gip or trigonal glp1/gip/glucagon agonists
MY170713A (en) Treatment protocol of diabetes type 2
PH12014500559B1 (en) Plant disease control composition and its use
GEP20156397B (en) Process for the preparation of a rivaroxaban and intermediates formed in said process
IL226386A0 (en) Therapeutic treatment for metabolic syndrome, type 2 diabetes, obestiy or prediabetes
WO2011117360A3 (en) Process for the preparation of 4-cyclohexyl-2-methyl-2-butanol
WO2014167428A3 (en) Amorphous 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-n-methylbenzamide
NZ703876A (en) Methods of using sialic acid and siaic acid precursors for the treatment of kidney disease and related conditions
WO2012093271A8 (en) A new palladium catalyst, method for its preparation and its use
WO2012087030A3 (en) Method for manufacturing toner
WO2011000945A3 (en) Aminoalkamides for use in the treatment of inflammatory, degenerative or demyelinating diseases of the cns
HUP1100179A2 (en) Self-cleaning, auxiliary-controlled main valve with mechanical operating mechanism, particularly for high-performance pipe networks
WO2009014127A1 (en) Composition for prevention or treatment of disease associated with the production of autoantibody
Sharaykina SOMATOTIPOLOGIChESKAYa I VOZRASTNAYa KhARAKTERISTIKA MUZhChIN, STRADAYuShchIKh KhRONIChESKOY OBSTRUKTIVNOY BOLEZN'Yu LEGKIKh
Грицюк et al. Streptozotocin model of diabetes mellitus
Zhi-Wu et al. Schistosomiasis haematobia misdiagnosed as urinary trace infection: one case report
Kaymarazova Uchenyy-istorik, arkhivist (K 70-letiyu so dnya rozhdeniya GI Kakagasanova)
Qing-Jun Memoriesof My University Life

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 03 JUN 2018 BY AJ PARK

Effective date: 20161021

S38C Proceedings under section 38 (amendment of specification with leave of commissioner): specification amended
S38C Proceedings under section 38 (amendment of specification with leave of commissioner): specification amended
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 JUN 2019 BY CPA GLOBAL

Effective date: 20180419

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 JUN 2020 BY CPA GLOBAL

Effective date: 20190523

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 JUN 2021 BY CPA GLOBAL

Effective date: 20200603

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 JUN 2022 BY CPA GLOBAL

Effective date: 20210610

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 JUN 2023 BY AJ PARK

Effective date: 20221203

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 JUN 2024 BY AJ PARK

Effective date: 20230524

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 JUN 2025 BY PATRIX IP SERVICES AB

Effective date: 20240516

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 JUN 2026 BY PATRIX IP SERVICES AB

Effective date: 20250509